Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2014
03/19/2014CN103638050A Fish oil nanoliposome preparation method
03/19/2014CN103638047A Preparation method of testicle tablet
03/19/2014CN103638046A Diclofenac sodium tablet and preparation method thereof
03/19/2014CN103638029A MPO inhibitors for the treatment of huntington's disease and multiple system atrophy
03/19/2014CN103638003A Compositions rich in N-acylethanolamides
03/19/2014CN103637999A Multi-layer solid drug dosage form
03/19/2014CN103637998A Sustained-release tablet containing oxycodone and rotundine
03/19/2014CN103637997A Duloxetine hydrochloride medicament composition, enteric sustained release preparation and preparation method thereof
03/19/2014CN103637987A Liquid drug composition of oxycodone
03/19/2014CN103637984A Baicalin nanometer crystal and preparation method thereof
03/19/2014CN103637983A Pharmaceutical composition containing Nalmefene hydrochloride and preparation method of pharmaceutical composition
03/19/2014CN103637977A Drug-containing implants and methods of use thereof
03/19/2014CN103637601A Youth cervical spondylosis health-care drug pillow
03/19/2014CN103637268A Instant medlar sea sedge with function of improving memory
03/19/2014CN103637123A Chewable tablet for strengthening spleen and stomach and preparation method thereof
03/19/2014CN103271944B Full-powder type capsule preparation
03/19/2014CN103191374B Traditional Chinese medicine composition for treating insomnia and preparation method of oral preparation thereof
03/19/2014CN103156876B Medicine composition for treating central nervous system diseases and preparation method and application thereof
03/19/2014CN103041339B Traditional Chinese medicine composition for curing migraine and preparation method thereof
03/19/2014CN102805784B Preparation Method of traditional Chinese medicine for treating pruritus type insomnia
03/19/2014CN102764407B Traditional Chinese medicinal decoction for treating depression
03/19/2014CN102764385B Medicine for treating venereophobia and application of medicine
03/19/2014CN102764380B Traditional Chinese medicine composite for curing cerebrovascular disease sequelae
03/19/2014CN102688416B Nutritional health-care product for improving agrypnia
03/19/2014CN102657758B Traditional Chinese medical composition and preparation method and application thereof
03/19/2014CN102641470B New Chinese medicinal composition for treating liver channel stagnated heat
03/19/2014CN102526157B Application of safflower extract to prevention or treatment of neurodegeneration disease
03/19/2014CN102458478B Albumin-amyloid peptide conjugates and uses thereof
03/19/2014CN102335169B Application of indole-3-carbinol, diindolyl methane and derivatives thereof in preparation of medicaments for treating senile dementia
03/19/2014CN102307836B Compounds for use in the treatment of pain
03/19/2014CN102203068B Cyclohexane derivative and pharmaceutical use thereof
03/19/2014CN102058630B Valerian preparation for tranquilizing and allaying excitement and preparation method thereof
03/19/2014CN101879166B Carbostyril derivative and serotonin reuptake inhibitor for treating patients with mood disorders
03/19/2014CN101829280B Chinese medicinal herb formulation for preventing aypnia and promoting sweet sleep
03/19/2014CN101495456B Substituted pyridyl amide compounds as modulators of the histamine H3 receptor
03/18/2014US8674106 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/18/2014US8673979 Pharmaceutical compositions for headache, migraine, nausea and emesis
03/18/2014US8673978 Polymorphs and salts
03/18/2014US8673966 ALDH-2 inhibitors in the treatment of addiction
03/18/2014US8673931 Bicyclic heterocyclic spiro compounds
03/18/2014US8673928 Compounds and methods for kinase modulation, and indications therefor
03/18/2014US8673921 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
03/18/2014US8673916 Methods of treating disorders mediated by histamine H3 receptors using pyridazinone derivatives
03/18/2014US8673904 Epoxide inhibitors of cysteine proteases
03/18/2014US8673894 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
03/18/2014US8673892 Phenyl bicyclic methyl azetidine derivatives as sphingosine-1 phosphate receptors modulators
03/18/2014US8673355 Opioid agonist/antagonist combinations
03/18/2014US8673305 Methods of treatment with antibodies against the extracellular loops of C5aR
03/18/2014US8673293 Use of modified cells for the treatment of multiple sclerosis
03/18/2014CA2743562C Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
03/18/2014CA2740815C New uses for amino acid anticonvulsants
03/18/2014CA2652826C A composition comprising extracts of radix ginseng, folium ginkgo, stigma croci and glycine max and use thereof for treating ischemic cerebrovascular disease
03/18/2014CA2632893C (1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1h-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders
03/18/2014CA2469588C Highly concentrated stable meloxicam solutions for needleless injection
03/13/2014WO2014040076A1 Methods of treating neurological diseases
03/13/2014WO2014039908A1 Methods and compositions for regenerating hair cells and/or supporting cells
03/13/2014WO2014039504A1 Bolaamphiphilic compounds, compositions and uses thereof
03/13/2014WO2014039501A1 Bolaamphiphilic compounds, compositions and uses thereof
03/13/2014WO2014039434A1 Alkoxy pyrazoles as soluble guanylate cyclase activators
03/13/2014WO2014039411A1 Pyrrolone or pyrrolidinone melanin concentrating hormore receptor-1 antagonists
03/13/2014WO2014039138A1 Method for selectively inhibiting the activity of acat1 in the treatment of alzheimer's disease
03/13/2014WO2014038878A2 Composition for brain-neuron protection and brain-disease prevention, alleviation or treatment comprising muskrat musk
03/13/2014WO2014038623A1 3-(4-piperidyl)-indazole derivative
03/13/2014WO2014037881A1 Compositions and methods for parkinson's disease treatment by bdnf-flag gene transfer through neurotensin polyplex to nigral dopamine neurons
03/13/2014WO2014037532A1 Methods of treating alzheimer's disease and pharmaceutical compositions thereof
03/13/2014WO2014037412A1 Nootropic compositions for improving memory performance
03/13/2014WO2014036595A1 Compounds and methods for treating diseases or conditions associated with the central nervous system and/or neurite outgrowth
03/13/2014WO2013182946A3 Vilazodone hydrobromide, process for its preparation and vilazodone polymorphs
03/13/2014WO2013179144A3 Chemical suppressors of neurotoxicity in synucleinopathic diseases
03/13/2014WO2013175316A3 Dopaminergic modulators for the treatment of huntington's disease
03/13/2014US20140073701 Methods of preventing, treating and diagnosing disorders of protein aggregation
03/13/2014US20140073692 Highly purified ethyl epa and other epa derivatives
03/13/2014US20140073663 Method of providing sustained analgesia with buprenorphine
03/13/2014US20140073598 Multiple folate formulation and use thereof
03/13/2014US20140073046 Cell Populations Which Co-Express CD49C and CD90
03/13/2014US20140072623 Gastric retained gabapentin dosage form
03/13/2014US20140072532 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
03/13/2014DE102012018115A1 New aryl-N-(arylalkyl) carbamate compounds, used to prepare pharmaceutical composition for prophylactic and/or therapeutic treatment of diseases including e.g. acute and chronic neurogenic pain, and neurological and psychiatric diseases
03/13/2014DE102010062810B4 2-(R2-Thio)-10-[3-(4-R1-piperazin-1-yl)propyl]-10H-phenothiazine zur Behandlung neurodegenerativer Erkrankungen ausgewählt aus beta-Amyloidopathien und alpha-Synucleinopathien 2- (R2-thio) -10- [3- (4-R1-piperazin-1-yl) propyl] -10H-phenothiazine for the treatment of neurodegenerative diseases selected from beta-Amyloidopathien and alpha-synucleinopathies
03/12/2014EP2706116A1 Binding domain-immunoglobulin fusion proteins
03/12/2014EP2706113A1 Synthetic peptide capable of inducing expression of type-2 tnf receptor and use thereof
03/12/2014EP2705843A1 Therapeutic approaches for treating epilepsy and related disorders through reduction of epileptogenesis
03/12/2014EP2705841A1 Combinations of nootropic agents for treating cognitive dysfunctions
03/12/2014EP2705364A1 Novel treatment of pain
03/12/2014EP2705151A2 Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
03/12/2014EP2705013A1 Pentylenetetrazole derivatives
03/12/2014EP2704709A1 Macrocyclic lactones and use thereof
03/12/2014EP2704707A1 Novel benzofurane-piperidine compounds
03/12/2014CN103635570A Recombinant yeast expressing human H-ferritin
03/12/2014CN103635460A Compounds for the treatment of addiction
03/12/2014CN103635458A Trpv1 antagonists
03/12/2014CN103635446A Pentylenetetrazole derivatives
03/12/2014CN103635230A Proteostasis regulators
03/12/2014CN103635184A Soyasapogenol composition
03/12/2014CN103627602A Distilled spirit and preparation method thereof
03/12/2014CN103627586A Health-care glutinous rice wine and preparation method thereof
03/12/2014CN103626865A Secreted protein with chemotactic activity, as well as coding sequence and medicament usage thereof
03/12/2014CN103626845A Arylpyrrole-2-formamide dipeptide derivatives serving as glycogen phosphorylase inhibitor and preparation method and medical application thereof
03/12/2014CN103626844A Artificial synthetic wheat germ peptide and preparation method and application thereof
03/12/2014CN103626825A Liver-targeted glycogen phosphorylase inhibitor cholic acid derivative and preparation method and medical application thereof
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 1833